Expression and biological activity of genetic fusions between MalE, the maltose binding protein from Escherichia coli and portions of CD4, the T-cell receptor of the AIDS virus

Protein Expression and Purification

Volumn 8, Issue 3, 1996, Pages 319-331

  Clément, Jean Marie ^a   Jehanno, Muguette ^a   Popescu, Octavian ^a   Saurin, William ^a   Hofnung, Maurice ^a  

^a INSTITUT PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0030294684     PISSN: 10465928     EISSN: None     Source Type: Journal    
DOI: 10.1006/prep.1996.0107     Document Type: Article

References (49)

1. 1. Robey, E., and Axel, R. (1990) CD4: Collaborator in immune recognition and HIV infection. Cell 60, 697-700.
2. 2. Dalgleish, A. G., Beverly, P. C. L., Clapham, P. R., Crawford, D. H., Greaves, M. F., and Weiss, R. A. (1985) The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus. Nature 312, 763-766.
3. 3. Klatzmann, D., Barré-Sinoussi, F., Nugeyre, M. T., Dauguet, C., Vilmer, E., Griscelli, C., Brun-Vésinet, F., Rouzioux, C., Gluckman, J-C., Chermann, J-C., and Montagnier, L. (1984) Selective tropism of lymphadenopathy associated virus (LAV) for helper-inducer lymphocytes. Science 225, 59-63.
4. 4. Klatzmann, D., Champagne, E., Chamaret, S., Gruest, J., Guetard, D., Hercend, T., Gluckman, J-C., and Montagnier, L. (1985) T-Lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV. Nature 312, 767-768.
5. 5. Chao, B. H., Costopoulos, D. S., Curiel, T., Bertonis, J. M., Chisholm, P., Williams, C., Schooley, R. T., Rosa, J. J., Fisher, R. A., and Maraganore, J. M. (1989) A 113-amino acid fragment of CD4 produced in Escherichia coli blocks human immunodeficiency virus-induced cell fusion. J. Biol. Chem. 264, 5812-5817.
6. 6. Traunecker, A., Schneider, J., Kiefer, H., and Karjalainen, K. (1989) Highly efficient neutralization of HIV with recombinant CD4-immunoglobulin molecules. Nature 339, 68-70.
7. 7. Garlick, R. L., Kirschner, R. J., Eckenrode, F. M., Tarpley, W. G., and Tomich, C. S. (1990) Escherichia coli expression, purification, and biological activity of a truncated soluble CD4. AIDS Res. Hum. Retroviruses 6, 465-479.
8. 8. MacFerrin, K. D., Terranova, M. P., Schreiber, S. L., and Verdine, G. L. (1990) Overproduction and dissection of proteins by the expression-cassette polymerase chain reaction. Proc. Natl. Acad. Sci. USA 87, 1937-1941.
9. 9. Zverev, V. V., Shakhov, A. N., Nedospasov, S. A., Pugach, A. V., Sidorov, A.V., Maliushova, V.V., and Andzhaparidze, O.G. (1991) Cloning and expression of the CD4 receptor gene from human T-lymphocytes in Escherichia coli cells. Mol. Gen. Mikrobiol. Virusol. 34, 16-18.
10. 10. McCallus, D. E., Ugen, K. E., Sato, A. I., Williams, W. V., and Weiner, D. B. (1992) Construction of a recombinant bacterial human CD4 expression system producing a bioactive CD4 molecule. Viral Immunol. 5, 163-172.
11. 11. Zverev, V. V., Maliushova, V. V., Sidorov, A. V., Pugach, A. V., Shukhmina, N. R., Pule, E. R., Mel'nikova, N. L., and Andzhaparidze, O. G. (1994) The antiviral action of recombinant forms of the human T-lymphocyte CD4 receptor. Vopr. Virusol. 39, 56-59.
12. 12. Daar, E. S., Li, X. L., Mougdil, T., and Ho, D. D. (1990) High concentrations of recombinant soluble CD4 are required to neutralize primary human immunodeficiency virus type 1 isolates. Proc. Natl. Acad. Sci. USA 87, 6574-6578.
13. 13. Groenink, M., Moore, J. P., Broersen, S., and Schuittemaker, H. (1995) Equal levels of gp120 retention and neutralization resistance of phenotypically distinct primary human immunodeficiency virus type 1 variants upon soluble CD4 treatment. J. Virol. 69, 523-527.
14. 14. Schacker, T., Coombs, R. W., Collier, A. C., Zeh, J. E., Fox, I., Alam, J., Nelson, K., Eggert, E., and Corey, L. (1994) The effects of high-dose recombinant soluble CD4 on human immunodeficiency virus type 1 viremia. J. Infect. Dis. 169, 37-40.
15. 15. Schooley, R. T., Merigan, T. C., Gaut, P., Hirsch, M. S., Holodniy, M., Flynn, T., Liu, S., Byington, R. E., Henochowicz, S., Gubish, E., Spriggs, D., Kufe, D., Schindler, J., Dawson, A., Thomas, D., Hanson, D. G., Letwin, B., Liu, T., Gulinello, J., Kennedy, S., Fisher, R., and Ho, D. (1990) Recombinant soluble CD4 therapy in patients with the immunodeficiency syndrome (AIDS) and AIDS-related complex. Ann. Intern. Med. 112, 247-253.
16. 16. Kahn, J. O., Allan, J. D., Hodges, T. L., Kaplan, L. D., Arri, C. J., Fitch, H. F., Izu, A. E., Mordenti, J., Sherwin, S. A., Groopman, J. E., and Volberding, P. A. (1990) The safety and pharmacodynamics of recombinant CD4 (rCD4) in subjects with the acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. Ann. Intern. Med. 112, 254-261.
17. 17. Moore, J. P. (1995) Back to primary school. Nature 376, 115.
18. 18. Wei, X., Ghosh, S. K., Taylor, M. E., Johnson, V. A., Emini, E. A., Deutsch, P., Lifson, J. D., Bonhoeffer, S., Nowak, M. A., Hahn, B. H., Saag, M. S., and Leonard, J. M. (1995) Viral dynamics in human immunodeficiency virus type 1 infection. Nature 373, 117-122.
19. 19. Ho, D. D., Neumann, A. U., Perelson, A. S., Chen, W., and Leonard, J. M. (1995) Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 373, 123-126.
20. 20. Kellerman, O., and Szmelcmann, S. (1974) Active transport of maltose in Escherichia coli K12. Involvement of a periplasmic maltose-binding protein. Eur. J. Biochem. 47, 139-149.
21. 21. Ferenci, T., and Klotz, U. (1978) Affinity chromatographic isolation of the periplasmic maltose binding protein of Escherichia coli. FEBS Lett. 94, 213-217.
22. 22. Kirshman, D. A., De Ciechi, P. A., Bono, C. P., Zacheis, M. L., Schwartz, B. D., and Woulfe, S. L. (1995) Utilization of soluble fusion proteins for induction of T Cell proliferation. Cell. Immunol. 160, 193-198.
23. 23. Clément, J-M., Szmelcman, S., Jehanno, M., Martineau, P., Schwartz, O., and Hofnung, M. (1989) Propriétés neutralisantes pour le virus HIV d'une protéine hybride MalE-CD4 exprimée chez Escherichia coli et purifiable en une étape. C. R. Acad. Sci. Paris 308, 401-406.
24. 24. Szmelcman, S., Clément, J-M., Jehanno, M., Schwartz, O., Montagnier, L., and Hofnung, M. (1990) Export and one-step purification from Escherichia coli of a MalE-CD4 hybrid protein which neutralizes in vitro the Human Immunodeficiency Virus (HIV). J. AIDS 3, 859-872.
25. 25. Duplay, P., Szmelcman, S., Bedouelle, H., and Hofnung, M. (1987) Silent and functional changes in the periplasmic maltose-binding protein of Escherichia coli K12. I. Transport of maltose. J. Mol. Biol. 194, 663-673.
26. 26. Martineau, P., Guillet, J-G., Leclerc, C., and Hofnung, M. (1992) Expression of heterologous peptides at two permissive sites of the MalE protein: antigenicity and immunogenicity of foreign B-cell and T-cell epitopes. Gene 113, 35-46.
27. 27. Betton, J-M., Martineau, P., Saurin, W., and Hofnung, M. (1993) Location of tolerated insertions/deletions in the structure of the maltose binding protein. FEBS Lett. 325, 34-38.
28. 28. Duplay, P., Bedouelle, H., Fowler, A., Zabin, I., Saurin, W., and Hofnung, M. (1984) Sequences of the malE gene and of its product, the maltose-binding protein in Escherichia coli K12. J. Biol. Chem. 259, 10606-10613.
29. 29. Neu, H. C., and Heppel, L. A. (1965) The release of enzymes of E. coli by osmotic shock during the formation of spheroplasts. J. Biol. Chem. 240, 3685-3692.
30. 30. Clément, J-M., and Popescu, O. (1991) MalE as a tool for the production of heterologous proteins in Escherichia coli. Bull. Inst. Pasteur 89, 243-253.
31. + T cells by a complex of the 110k viral protein and the T4 molecule. Science 231, 382-385.
32. 32. Idziorek, T., and Klatzmann, D. (1991) Functional expression of the CD4 protein after cross-linking to red blood cells with a bifunctional reagent. Biochim. Biophys. Acta 1062, 39-45.
33. 33. Waxman, L., and Goldberg, A. L. (1985) Protease La, the lon gene product, cleaves specific fluorogenic peptides in an ATP-dependent reaction. J. Biol. Chem. 260, 12022-12028.
34. 34. Strauch, K. L., and Beckwith, J. (1988) An Escherichia coli mutation preventing degradation of abnormal periplasmic proteins. Proc. Natl. Acad. Sci. USA 85, 1576-1580.
35. 35. Strauch, K. L., Johnson, K., and Beckwith, J. (1989) Characterization of degP, a gene required for proteolysis in the cell envelope and essential growth of Escherichia coli at high temperature. J. Bacteriol. 171, 2689-2696.
36. 36. Grodberg, J., and Dunn, J. J. (1988) OmpT encodes the Escherichia coli outer membrane protease that cleaves T7 RNA polymerase during purification. J. Bacteriol. 170, 1245-1253.
37. 37. Baneyx, F., and Georgiou, G. (1990) In vivo degradation of secreted fusion proteins by the Escherichia coli outer membrane protease OmpT. J. Bacteriol. 172, 491-494.
38. 38. Richardson, N. E., Brown, N. R., Hussey, R. E., Vaid, A., Matthews, T. J., Bolognesi, D. P., and Reinherz, E. L. (1988) Binding site for human immunodeficiency virus coat protein gp120 is located in the NH2-terminal region of T4 (CD4) and requires the intact variable-region-like domain. Proc. Natl. Acad. Sci. USA 85, 6102-6106.
39. 39. Harris, R. J., Chamow, S. M., Gregory, T. J., and Spellman, M. W. (1990) Characterization of a soluble form of human CD4. Peptide analyses confirm the expected amino acid sequence, identify glycosylation sites and demonstrate the presence of three disulfide bonds. Eur. J. Biochem., 188, 291-300.
40. 40. Charbit, A., Martineau, P., Ronco, J., Leclerc, C., Lo-Man, R., Michel, V., O'Callaghan, D., and Hofnung, M. (1993) Expression and immunogenicity of the V3 loop from the envelope of human immunodeficiency virus type 1 in an attenuated aroA strain of Salmonella typhimurium upon genetic coupling to two Escherichia coli carrier proteins. Vaccine 11, 1221-1228.
41. 41. Sattentau, Q. J., Dalgleish, A. G., Weiss, R. A., and Beverley, P. C. L. (1986) Epitopes of the CD4 antigen and HIV infection. Science 234, 1120-1123.
42. 42. Clayton, L. K., Hussey, R. E., Steinbrich, R., Ramachandran, H., Husain, Y., and Reinherz, E. L. (1988) Substitution of murine for human CD4 residues identifies amino acids critical for HIV-gp120 binding. Nature 335, 363-366.
43. 43. Peterson, A., and Seed, B. (1988) Genetic analysis of monoclonal antibody and HIV binding sites on the human lymphocyte antigen CD4. Cell 54, 65-72.
44. 44. Ashkenazi, A., Presta, L. G., Marsters, S.A., Camerato, T. R., Rosenthal, K. A., Fendly, B. M., and Capon, D. J. (1990) Mapping the CD4 binding site for human immunodeficiency virus by alanine-scanning mutagenesis. Proc. Natl. Acad. Sci. USA 87, 7150-7154.
45. 45. Brodsky, M. H., Warton, M., Myers, R. M., and Littman, D. R. (1990) Analysis of the site in CD4 that binds to the HIV envelope glycoprotein. J. Immunol. 144, 3078-3086.
46. 46. Wang, J. H., Yan, Y., Garrett, T. P. J., Liu, J., Rodgers, D. W., Garlick, R. L., Tarr, G. E., Husain, Y., Reinherz, E. L., and Harrison, S. C. (1990) Atomic structure of a fragment of human CD4 containing two immunoglobulin-like domains. Nature 348, 411-418.
47. 47. Ryu, S. E., Kwong, P. D., Truneh, A., Porter, T. G., Arthos, J., Rosenberg, M., Dai, X., Xuong, N. H., Axel, R., Sweet, R. W., and Hendrickson, W. A. (1990) Crystal structure of an HIV-binding recombinant fragment of human CD4. Nature 348, 419-426.
48. 48. Garrett, T. P., Wang, J., Yan, Y., Liu, J., and Harrison, S. C. (1993) Refinement and analysis of the structure of the first two domains of human CD4. J. Mol. Biol. 234, 763-778.
49. 49. Spurlino, J. C., Lu, G. Y., and Quiocho, F. A. (1991) The 2.3-A resolution structure of the maltose-binding or maltodextrin-binding protein, a primary receptor of bacterial active transport and chemotaxis. J. Biol. Chem. 266, 5202-5219.